Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Una Hajdari

The Ozempic effect: From shopping baskets to dips in Danish GDP

Denmark sliced its 2025 economic growth forecast in half recently after a cool-down at Novo Nordisk, the maker of diabetes drugs Ozempic and Wegovy, which have become popular among those wanting to quickly shed some pounds.

The dip in its growth forecast from 3% to 1.4% comes in large part due to weaker expectations for pharmaceutical giant Novo Nordisk—after the economy expanded by 3.7% last year due to a major boost from pharmaceutical exports.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.